FDA On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula), Says If Feasible Use KP.2 Strain Of JN.1-Lineage
FDA On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula), Says If Feasible Use KP.2 Strain Of JN.1-Lineage
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.